✦ LIBER ✦

Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: Studies on the possible mechanism of action in DU145 cells

✍ Scribed by A. Pravettoni; O. Mornati; P.G.V. Martini; M. Marino; A. Colciago; F. Celotti; M. Motta; P. Negri-Cesi

Book ID: 116734061
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 545 KB
Volume: 263
Category: Article
ISSN: 0303-7207
DOI: 10.1016/j.mce.2006.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of anti-estrogens on the androgen

Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells

✍ Kawashima, Hidenori ;Tanaka, Tomoaki ;Cheng, Jed-Sian ;Sugita, Syozo ;Ezaki, Kaz 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 284 KB

Estrogen receptor beta increases the eff

Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells

✍ Leslie Hodges-Gallagher; Cathleen D. Valentine; Suzy El Bader; Peter J. Kushner 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 373 KB

Targeted inhibition of the epidermal gro

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (‘Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells

✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

Characterization of the expression of va

Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

✍ B. Desai; T. Ma; J. Zhu; M.A. Chellaiah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

## Abstract CD44 is a glycosylated adhesion molecule and osteopontin is one of its ligand. CD44 undergoes alternative splicing to produce variant isoforms. Our recent studies have shown an increase in the surface expression of CD44 isoforms (sCD44 and v4–v10 variant CD44) in prostate cancer cells o